Showing results (21-30 of 324) with videos related to
Sort By:
Pageof 33
International Journal of Cancer|January 27, 2009
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancerAlain G Zeimet, Daniel Reimer, Dominik Wolf, et al.World Journal of Clinical Oncology|August 11, 2022
Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignanciesPatrick Kirchweger, Helwig Valentin Wundsam, Holger RumpoldClinical Immunology (Orlando, Fla.)|September 24, 2004
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel diseaseAnna Maria Wolf, Dominik Wolf, Holger Rumpold, et al.Journal of Cancer Research and Clinical Oncology|January 3, 2022
Improvement in colorectal cancer outcomes over time is limited to patients with left-sided diseaseHolger Rumpold, M Hackl, A Petzer, et al.Deutsche Medizinische Wochenschrift (1946)|March 15, 2022
[What's new in myeloproliferative neoplasia?]Stefan Schmidt, Dominik WolfExpert Review of Hematology|November 19, 2010
Role of gene-expression profiling in chronic myeloid leukemiaStefan Schmidt, Dominik WolfOncotarget|December 12, 2018
Correction: Molecular response prediction in CML: novel ideas?Dominik Wolf, Sieghart SopperDeutsche Medizinische Wochenschrift (1946)|November 2, 2023
[Recent findings in myelodysplastic syndrome]Verena Petzer, Dominik WolfExpert Review of Hematology|April 19, 2011
Dose escalation of imatinib in chronic-phase chronic myeloid leukemia patients: is it still reasonable?Jakob Rudzki, Dominik WolfCancer Immunology Research|April 1, 2022
IFNγ Helps CBLB-Deficient CD8+ T Cells to Put Up Resistance to TregsDominik Wolf, Gottfried BaierPageof 33